Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms
Authors:
- Benjamin B. StraussBSBenjamin B. Strauss
- Tracy C. YabTYTracy C. Yab
- Helen M. O’cOnnorHOHelen M. O’cOnnor
- William R. TaylorWTWilliam R. Taylor
- Douglas W. MahoneyDMDouglas W. Mahoney
- Julie A. SimonsonJSJulie A. Simonson
- John ChristensenJCJohn Christensen
- Suresh T. ChariSCSuresh T. Chari
- David A. AhlquistDADavid A. Ahlquist
- 22 August 2015
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 61 (1) , 117-125
Abstract
Background Stool DNA testing represents a potential noninvasive approach to detect upper gastrointestinal (UGI) neoplasms. However, little is known about fecal recovery efficiency of DNA exfoliated from UGI tumors. Aims The purpose of this study was to establish a human ingestion model that quantitatively approximates daily cellular shedding from UGI neoplasms and to estimate fecal DNA marker recovery rates. Methods Healthy volunteers (n = 10) ingested two scheduled doses of raw salmon, 0.3 and 30 g, simulating the mass exfoliated daily from 1 to 4.5 cm lesions. To approach a steady-state, each dose was ingested over three consecutive days in randomized order. Following defecation of an indicator dye ingested with test meals, stools were collected over 48 h. Ingested salmon DNA was captured from stools using probes targeting pathognomonic Salmonidae sequences (SlmII). Captured DNA was quantified using PCR primers to generate 178, 138, 88 and 55 bp amplicons. Results SlmII sequences were recovered from all stools following salmon ingestion; recovery was proportional to amount ingested (p = 0.004). Fecal recovery of ingested salmon varied inversely with amplicon size targeted; mean recovery rates of SlmII were 0.49, 0.91, 3.63, and 7.31 copies per 100,000 copies ingested for 178, 134, 88, and 55 bp amplicons, respectively (p < 0.0001). Longer oro-anal transit was associated with reduced recovery. Conclusions While recovery efficiencies are low, ingested cellular DNA simulating daily amounts shed from UGI tumors can readily be detected in stool. Assay of shorter-fragment analyte increases recovery. This ingestion model has potential value in studying the effects of perturbations relevant to the fecal recovery of DNA exfoliated from UGI tumors.Keywords
Funding Information
- Eugene and Eve Lane
This publication has 34 references indexed in Scilit:
- Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large AdenomasGastroenterology, 2012
- Stool DNA testing for the detection of pancreatic cancerCancer, 2011
- High Fragmentation Characterizes Tumour-Derived Circulating DNAPLOS ONE, 2011
- Next-Generation Stool DNA Testing: Expanding the ScopeGastroenterology, 2009
- Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer PatientsGastroenterology, 2008
- Retroposons of salmonoid fishes (Actinopterygii: Salmonoidei) and their evolutionGene, 2008
- Primer3Plus, an enhanced web interface to Primer3Nucleic Acids Research, 2007
- Novel SINE Families from Salmons Validate Parahucho (Salmonidae) as a Distinct Genus and Give Evidence that SINEs Can Incorporate LINE-related 3′-Tails of Other SINEsMolecular Biology and Evolution, 2007
- Epithelial Stem Cells: Turning over New LeavesCell, 2007
- BLAT—The BLAST-Like Alignment ToolGenome Research, 2002